The results on the survival rate and occurrence of severe proteinuria in this study suggest that obesity induced by HFD significantly reduced the therapeutic effect of methylprednisolone in SLE, in a process probably involving proinflammatory cytokines such as IL-6, MCP-1 and TNF-α, and adipokines. This evidence concerns the gene CCL2 and obesity disorder.